- Home
- FURY vs BEAT Comparison
FURY vs BEAT Comparison
Compare FURY & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FURY
- BEAT
- Stock Information
- Founded
- FURY 2008
- BEAT 2015
- Country
- FURY Canada
- BEAT United States
- Employees
- FURY N/A
- BEAT N/A
- Industry
- FURY Precious Metals
- BEAT Retail: Computer Software & Peripheral Equipment
- Sector
- FURY Basic Materials
- BEAT Technology
- Exchange
- FURY Nasdaq
- BEAT Nasdaq
- Market Cap
- FURY 59.5M
- BEAT 62.7M
- IPO Year
- FURY N/A
- BEAT 2021
- Fundamental
- Price
- FURY $0.41
- BEAT $2.27
- Analyst Decision
- FURY Strong Buy
- BEAT Buy
- Analyst Count
- FURY 1
- BEAT 1
- Target Price
- FURY $2.00
- BEAT $8.00
- AVG Volume (30 Days)
- FURY 181.3K
- BEAT 99.5K
- Earning Date
- FURY 11-12-2024
- BEAT 11-07-2024
- Dividend Yield
- FURY N/A
- BEAT N/A
- EPS Growth
- FURY N/A
- BEAT N/A
- EPS
- FURY N/A
- BEAT N/A
- Revenue
- FURY N/A
- BEAT N/A
- Revenue This Year
- FURY N/A
- BEAT N/A
- Revenue Next Year
- FURY N/A
- BEAT N/A
- P/E Ratio
- FURY N/A
- BEAT N/A
- Revenue Growth
- FURY N/A
- BEAT N/A
- 52 Week Low
- FURY $0.32
- BEAT $1.06
- 52 Week High
- FURY $0.59
- BEAT $3.39
- Technical
- Relative Strength Index (RSI)
- FURY 37.64
- BEAT 46.37
- Support Level
- FURY $0.39
- BEAT $2.33
- Resistance Level
- FURY $0.48
- BEAT $2.61
- Average True Range (ATR)
- FURY 0.04
- BEAT 0.19
- MACD
- FURY -0.01
- BEAT -0.02
- Stochastic Oscillator
- FURY 10.28
- BEAT 9.80
About FURY Fury Gold Mines Limited
Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.